Published Online
on October 7, 2004

A more recent version of this article appeared on November 1, 2004

This Article Full Text (PDF) All Versions of this Article: 35/11_suppl_1/2648    most recent 01.STR.0000143734.59507.88v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simpkins, J. W. Articles by Green, P. S. Search for Related Content PubMed PubMed Citation Articles by Simpkins, J. W. Articles by Green, P. S. Related Collections Acute coronary syndromes

Submitted on June 2, 2004
Accepted on June 2, 2004

Estrogen-Like Compounds for Ischemic Neuroprotection

James W. Simpkins PhD^*; Shao-Hua Yang MD, PhD; Ran Liu MD; Evelyn Perez PhD; Zu Yun Cai PhD; Douglas F. Covey PhD; and Pattie S. Green PhD

From the Department of Pharmacology & Neuroscience (J.W.S., S.-H.Y., R.L., E.P.), University of North Texas Health Science Center, Fort Worth, Texas; the Department of Molecular Biology and Pharmacology (Z.Y.C., D.F.C.), Washington University School of Medicine, St. Louis, Mo; and the Department of Gerontology and Geriatric Medicine (P.S.G.), School of Medicine, University of Washington, Seattle, Wash.

^* To whom correspondence should be addressed. E-mail: jsimpkin{at}hsc.unt.edu.

Abstract--We have synthesized a library of estrogen analogues, including enantiomers of estradiol and A-ring substituted estrogens. These compounds have reduced or no binding to either estrogen receptor- or estrogen receptor-, exhibit enhanced neuroprotective activity in in vitro models, and are potent in protecting brain tissue from cerebral ischemia/reperfusion injury. These potent, nonfeminizing estrogen analogues are prime candidates for use in stroke neuroprotection.

Key words: estrogens • estrogen receptors • neuroprotection • stroke

This article has been cited by other articles:

				M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System Endocr. Rev., June 1, 2007; 28(4): 387 - 439. [Abstract] [Full Text] [PDF]

				S. Kousteni, M. Almeida, L. Han, T. Bellido, R. L. Jilka, and S. C. Manolagas Induction of Osteoblast Differentiation by Selective Activation of Kinase-Mediated Actions of the Estrogen Receptor Mol. Cell. Biol., February 15, 2007; 27(4): 1516 - 1530. [Abstract] [Full Text] [PDF]

				M. E. Jung, A. M. Wilson, and J. W. Simpkins A Nonfeminizing Estrogen Analog Protects against Ethanol Withdrawal Toxicity in Immortalized Hippocampal Cells J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 543 - 550. [Abstract] [Full Text] [PDF]